Search Within

Leonard B Saltz

  1. "William Jarnagin"
Formats
  1. Journal Article (13)
  2. Meeting Abstract (7)
Groups
  1. Center for Pancreatic Cancer Research (20)
  2. Department of Medicine (20)
  3. Gastrointestinal Oncology Service (20)
  4. Solid Tumor Oncology Division (20)
  5. Surgery (20)
  6. Epidemiology and Biostatistics (15)

More Groups

People
  1. William Jarnagin (20)
  2. Michael D'Angelica (15)
  3. Nancy Kemeny (15)
  4. Ronald DeMatteo (9)
  5. T Peter Kingham (9)
  6. Mithat Gonen (8)

More People

Years
  1. 2022 (1)
  2. 2020 (2)
  3. 2018 (2)
  4. 2017 (3)
  5. 2016 (2)
  6. 2014 (3)

More Years

Publications
  1. Journal of Clinical Oncology (7)
  2. Annals of Surgical Oncology (4)
  3. Clinical Cancer Research (3)
  4. Cancer (1)
  5. JAMA Oncology (1)
  6. Journal of the American College of Surgeons (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (7)
  2. Springer (4)
  3. American Association for Cancer Research (3)
  4. American Medical Association (1)
  5. C M P Medica LLC * The Oncology Group (1)
  6. Elsevier Science, Inc. (1)

More Publishers

Results (20)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Recurrence-free survival versus overall survival as a primary end point for resectable colorectal liver metastasis studies: Analysis of 2,983 curative-intent hepatectomies
    Meeting Abstract

    Ecker, B.; Lee, J.; Saadat, L. V.; Balachandran, V. P.; Drebin, J.; Jarnagin, W. R.; Kemeny, N. E.; Kingham, T. P.; Saltz, L.; Soares, K. C.; more...
    Annals of Surgical Oncology (2022)

    Fulltext@MSK | Save
  • Coaltered Ras/B-raf and TP53 is associated with extremes of survivorship and distinct patterns of metastasis in patients with metastatic colorectal cancer
    Journal Article

    Datta, J.; Smith, J. J.; Chatila, W. K.; McAuliffe, J. C.; Kandoth, C.; Vakiani, E.; Frankel, T. L.; Ganesh, K.; Wasserman, I.; Lipsyc-Sharf, M.; more...
    Clinical Cancer Research (2020)

    Fulltext@MSK | Save
  • Assessment of hepatic arterial infusion of floxuridine in combination with systemic gemcitabine and oxaliplatin in patients with unresectable intrahepatic cholangiocarcinoma: A phase 2 clinical trial
    Journal Article

    Cercek, A.; Boerner, T.; Tan, B. R.; Chou, J. F.; Gönen, M.; Boucher, T. M.; Hauser, H. F.; Do, R. K. G.; Lowery, M. A.; Harding, J. J.; more...
    JAMA Oncology (2020)

    Fulltext@MSK | Save
  • Comprehensive molecular profiling of intrahepatic and extrahepatic cholangiocarcinomas: Potential targets for intervention
    Journal Article

    Lowery, M. A.; Ptashkin, R.; Jordan, E.; Berger, M. F.; Zehir, A.; Capanu, M.; Kemeny, N. E.; O'Reilly, E. M.; El-Dika, I.; Jarnagin, W. R.; more...
    Clinical Cancer Research (2018)

    Fulltext@MSK | Save
  • The impact of primary tumor location on long-term survival in patients undergoing hepatic resection for metastatic colon cancer
    Journal Article

    Creasy, J. M.; Sadot, E.; Koerkamp, B. G.; Chou, J. F.; Gonen, M.; Kemeny, N. E.; Saltz, L. B.; Balachandran, V. P.; Kingham, T. P.; DeMatteo, R. P.; more...
    Annals of Surgical Oncology (2018)

    Fulltext@MSK | Save
  • Right versus left: Impact of primary location on survival and cure in patients undergoing hepatic resection for metastatic colon cancer
    Meeting Abstract

    Creasy, J. M.; Sadot, E.; Koerkamp, B. G.; Chou, J. F.; Gonen, M.; Kemeny, N. E.; Cercek, A.; Saltz, L.; Balachandran, V. P.; Kingham, T. P.; more...
    Journal of Clinical Oncology (2017)

    Fulltext@MSK | Save
  • Real-time genomic profiling of pancreatic ductal adenocarcinoma: Potential actionability and correlation with clinical phenotype
    Journal Article

    Lowery, M. A.; Jordan, E. J.; Basturk, O.; Ptashkin, R. N.; Zehir, A.; Berger, M. F.; Leach, T.; Herbst, B.; Askan, G.; Maynard, H.; more...
    Clinical Cancer Research (2017)

    Fulltext@MSK | Save
  • MicroRNA-203 predicts human survival after resection of colorectal liver metastasis
    Journal Article

    Kingham, T. P.; Nguyen, H. C. B.; Zheng, J.; Konstantinidis, I. T.; Sadot, E.; Shia, J.; Kuk, D.; Zhang, S.; Saltz, L.; D'Angelica, M. I.; more...
    Oncotarget (2017)

    Fulltext@MSK | Save
  • Comprehensive molecular profiling and analysis of mutual exclusivity of genetic aberrations (MEGA) of intra- and extrahepatic cholangiocarcinomas (IHC and EHC) evaluation of prognostic features and potential targets for intervention
    Meeting Abstract

    Lowery, M. A.; Ptashkin, R.; Jordan, E.; Berger, M. F.; Zehir, A.; Kemeny, N. E.; O'Reilly, E. M.; Jarnagin, W. R.; Harding, J. J.; DeMatteo, R. P.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save
  • Identification of potentially actionable molecular alterations in advanced hepatocellular carcinoma (HCC)
    Meeting Abstract

    Harding, J. J.; Heins, Z. J.; Connell, L. C.; Soumerai, T.; Kemeny, N. E.; Jarnagin, W. R.; O'Reilly, E. M.; DeMatteo, R. P.; D'Angelica, M. I.; Lowery, M. A.; more...
    Journal of Clinical Oncology (2016)

    Fulltext@MSK | Save